Symbol="CGTX"
AssetType="Common Stock"
Name="Cognition Therapeutics Inc"
Description="Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company is headquartered in Purchase, New York."
CIK="1455365"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2403 SIDNEY STREET, SUITE 261, PITTSBURGH, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="50650000"
EBITDA="-43025000"
PERatio="None"
PEGRatio="None"
BookValue="1.222"
DividendPerShare="0"
DividendYield="0"
EPS="-0.88"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.516"
ReturnOnEquityTTM="-0.561"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.88"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.967"
EVToRevenue="-"
EVToEBITDA="-1.348"
Beta="None"
num_52WeekHigh="3.83"
num_52WeekLow="1.07"
num_50DayMovingAverage="2.205"
num_200DayMovingAverage="1.991"
SharesOutstanding="29277200"
DividendDate="None"
ExDividendDate="None"
symbol="CGTX"
open="1.70"
high="1.79"
low="1.66"
price="1.77"
volume="30687.00"
latest_trading_day="2023-08-03"
previous_close="1.73"
change="0.04"
change_percent="2.3121%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="44"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="125315"
Change_recent_avg="0.01"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.48"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_negative_thumbnail_id_2="113"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0063.jpeg"
image_neutral_thumbnail_id_1="563"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="628"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_positive_thumbnail_id_2="672"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
